Impact of cognitive functions on oral anticancer therapies adherence

被引：0
|
作者：
Dos Santos, M. [1 ]
Lange, M. [2 ]
Clarisse, B. [2 ]
Barillet, M. [2 ]
Joly, F. [1 ]
机构：
[1] Ctr Francois Baclesse, Med Oncol, Caen, France
[2] Ctr Francois Baclesse, Clin Res Dept, Caen, France
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1497P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence
    Mélanie Dos Santos
    M. Lange
    R. Gervais
    B. Clarisse
    A. Capel
    M. Barillet
    J. M. Grellard
    N. Heutte
    I. Licaj
    F. Joly
    Supportive Care in Cancer, 2019, 27 : 3573 - 3581
  • [2] Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence
    Dos Santos, Melanie
    Lange, M.
    Gervais, R.
    Clarisse, B.
    Capel, A.
    Barillet, M.
    Grellard, J. M.
    Heutte, N.
    Licaj, I.
    Joly, F.
    SUPPORTIVE CARE IN CANCER, 2019, 27 (09) : 3573 - 3581
  • [3] Managing adherence, exposure, and toxicity in oral anticancer therapies
    Kazuo Kobayashi
    Journal of Pharmaceutical Health Care and Sciences, 11 (1)
  • [4] An interprofessional medication adherence program to optimize adherence to oral anticancer therapies: a randomized-controlled trial
    Bandiera, Carole
    Cardoso, Evelina
    Locatelli, Isabella
    Digklia, Antonia
    Zaman, Khalil
    Diciolla, Antonella
    Cristina, Vale Prime Rie
    Stravodimou, Athina
    Veronica, Aedo-Lopez
    Dolcan, Ana
    Sarivalasis, Apostolos
    Bouchaab, Hasna
    Liapi, Aikaterini
    Orcurto, Angela
    Dotta-Celio, Jennifer
    Peters, Solange
    Decosterd, Laurent
    Widmer, Nicolas
    Wagner, Dorothea
    Csajka, Chantal
    Schneider, Marie P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (01)
  • [5] Adherence with Oral Anticancer Agents
    Timmers, Lonneke
    Kropff, Femke
    Boons, Christel C. L. M.
    van de Ven, Peter
    Swart, Eleonora L.
    Boven, Epie
    Hugtenburg, Jacqueline
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 460 - 461
  • [6] Adherence to novel oral anticancer therapies in the phase I setting: The Royal Marsden experience.
    Chenard-Poirier, Maxime
    Ang, Joo Ern
    Harris, Samuel John
    Garces, Alvaro Henrique Ingles
    Seeramreddi, Satyanarayana
    Sundar, Raghav
    Collins, Dearbhaile Catherine
    Ameratunga, Malaka
    Lopez, Juanita Suzanne
    De Bono, Johann S.
    Banerji, Udai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Oral toxicity of targeted anticancer therapies
    Sibaud, V.
    Boralevi, F.
    Vigarios, E.
    Fricain, J. -C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2014, 141 (05): : 354 - 363
  • [8] Oral Mucositis Induced By Anticancer Therapies
    Al-Ansari S.
    Zecha J.A.E.M.
    Barasch A.
    de Lange J.
    Rozema F.R.
    Raber-Durlacher J.E.
    Current Oral Health Reports, 2015, 2 (4) : 202 - 211
  • [9] Patient adherence with oral anticancer treatment
    Costantini, A.
    Santoleri, F.
    Sorice, P.
    Scurti, V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 965 - 966
  • [10] Patient adherence to oral anticancer drugs
    Eberl, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S28 - S28
12345